Advances in the Modulation of ROS and Transdermal Administration for Anti-Psoriatic Nanotherapies

Scientists emphasize the underlying molecular mechanism of reactive oxygen species (ROS)-based nanoreactors for improved therapeutic outcomes against psoriasis, and summarize up-to-date progress relating to the advantages and limitations of nanotherapeutic application for transdermal administration.